prof. Piet Ost demonstrates new treatment options for patients with metastasized prostate cancer

CRIG group leader prof. Piet Ost and co-workers demonstrated that prostate cancer patients with maximum 3 metastatic lesions can benefit from removing the lesions (via surgery or radiotherapy). This allows to delay hormone therapy, which has important side effects.

Link to the publication in Journal of Clinical Oncology.
Follow on Twitter, and read articles (in Dutch) from 'De Morgen', 'Het Nieuwsblad' and 'Het Laatste Nieuws'.